Europe Generic Drugs Market Report 2017

January 2017 | 111 pages | ID: ED105672AD4EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Generic Drugs

Revenue, means the sales value of Generic Drugs

This report studies sales (consumption) of Generic Drugs in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

• Teva Pharma.
• Novartis company
• Mylan
• Allergan
• Hospira
• Dr. Reddy’s Lab.
• Stada
• Greenstone
• Par Pharma
• Sun Pharmaceutical
• Aspen Pharmacare
• Fresenius
• Lupin

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Generic Drugs in these countries, from 2011 to 2021 (forecast), like

• Germany
• France
• UK
• Russia
• Italy
• Spain
• Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Pure (Non-branded) Generics
• Branded Generics
• Super Generics

Split by application, this report focuses on sales, market share and growth rate of Generic Drugs in each application, can be divided into

• Cardiovascular & Hypertension
• Dermatology
• Diabetes
• Rheumatology
• Oncology
• Gastrointestinal
• Others

Contents

Europe Generic Drugs Market Report 2017

1 GENERIC DRUGS OVERVIEW

1.1 Product Overview and Scope of Generic Drugs
1.2 Classification of Generic Drugs
  1.2.1 Pure (Non-branded) Generics
  1.2.2 Branded Generics
  1.2.3 Super Generics
1.3 Application of Generic Drugs
  1.3.1 Cardiovascular & Hypertension
  1.3.2 Dermatology
  1.3.3 Diabetes
  1.3.4 Rheumatology
  1.3.5 Oncology
  1.3.6 Gastrointestinal
  1.3.7 Others
1.4 Generic Drugs Market by Countries
  1.4.1 Germany Status and Prospect (2011-2021)
  1.4.2 France Status and Prospect (2011-2021)
  1.4.3 UK Status and Prospect (2011-2021)
  1.4.4 Russia Status and Prospect (2011-2021)
  1.4.5 Italy Status and Prospect (2011-2021)
  1.4.6 Spain Status and Prospect (2011-2021)
  1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Generic Drugs (2011-2021)
  1.5.1 Europe Generic Drugs Sales and Growth Rate (2011-2021)
  1.5.2 Europe Generic Drugs Revenue and Growth Rate (2011-2021)

2 EUROPE GENERIC DRUGS BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Europe Generic Drugs Market Competition by Manufacturers
  2.1.1 Europe Generic Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Europe Generic Drugs Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Generic Drugs (Volume and Value) by Type
  2.2.1 Europe Generic Drugs Sales and Market Share by Type (2011-2016)
  2.2.2 Europe Generic Drugs Revenue and Market Share by Type (2011-2016)
2.3 Europe Generic Drugs (Volume and Value) by Countries
  2.3.1 Europe Generic Drugs Sales and Market Share by Countries (2011-2016)
  2.3.2 Europe Generic Drugs Revenue and Market Share by Countries (2011-2016)
2.4 Europe Generic Drugs (Volume) by Application

3 GERMANY GENERIC DRUGS (VOLUME, VALUE AND SALES PRICE)

3.1 Germany Generic Drugs Sales and Value (2011-2016)
  3.1.1 Germany Generic Drugs Sales and Growth Rate (2011-2016)
  3.1.2 Germany Generic Drugs Revenue and Growth Rate (2011-2016)
  3.1.3 Germany Generic Drugs Sales Price Trend (2011-2016)
3.2 Germany Generic Drugs Sales and Market Share by Manufacturers
3.3 Germany Generic Drugs Sales and Market Share by Type
3.4 Germany Generic Drugs Sales and Market Share by Application

4 FRANCE GENERIC DRUGS (VOLUME, VALUE AND SALES PRICE)

4.1 France Generic Drugs Sales and Value (2011-2016)
  4.1.1 France Generic Drugs Sales and Growth Rate (2011-2016)
  4.1.2 France Generic Drugs Revenue and Growth Rate (2011-2016)
  4.1.4 France Generic Drugs Sales Price Trend (2011-2016)
4.2 France Generic Drugs Sales and Market Share by Manufacturers
4.3 France Generic Drugs Sales and Market Share by Type
4.4 France Generic Drugs Sales and Market Share by Application

5 UK GENERIC DRUGS (VOLUME, VALUE AND SALES PRICE)

5.1 UK Generic Drugs Sales and Value (2011-2016)
  5.1.1 UK Generic Drugs Sales and Growth Rate (2011-2016)
  5.1.2 UK Generic Drugs Revenue and Growth Rate (2011-2016)
  5.1.5 UK Generic Drugs Sales Price Trend (2011-2016)
5.2 UK Generic Drugs Sales and Market Share by Manufacturers
5.3 UK Generic Drugs Sales and Market Share by Type
5.4 UK Generic Drugs Sales and Market Share by Application

6 RUSSIA GENERIC DRUGS (VOLUME, VALUE AND SALES PRICE)

6.1 Russia Generic Drugs Sales and Value (2011-2016)
  6.1.1 Russia Generic Drugs Sales and Growth Rate (2011-2016)
  6.1.2 Russia Generic Drugs Revenue and Growth Rate (2011-2016)
  6.1.6 Russia Generic Drugs Sales Price Trend (2011-2016)
6.2 Russia Generic Drugs Sales and Market Share by Manufacturers
6.3 Russia Generic Drugs Sales and Market Share by Type
6.4 Russia Generic Drugs Sales and Market Share by Application

7 ITALY GENERIC DRUGS (VOLUME, VALUE AND SALES PRICE)

7.1 Italy Generic Drugs Sales and Value (2011-2016)
  7.1.1 Italy Generic Drugs Sales and Growth Rate (2011-2016)
  7.1.2 Italy Generic Drugs Revenue and Growth Rate (2011-2016)
  7.1.7 Italy Generic Drugs Sales Price Trend (2011-2016)
7.2 Italy Generic Drugs Sales and Market Share by Manufacturers
7.3 Italy Generic Drugs Sales and Market Share by Type
7.4 Italy Generic Drugs Sales and Market Share by Application

8 SPAIN GENERIC DRUGS (VOLUME, VALUE AND SALES PRICE)

8.1 Spain Generic Drugs Sales and Value (2011-2016)
  8.1.1 Spain Generic Drugs Sales and Growth Rate (2011-2016)
  8.1.2 Spain Generic Drugs Revenue and Growth Rate (2011-2016)
  8.1.8 Spain Generic Drugs Sales Price Trend (2011-2016)
8.2 Spain Generic Drugs Sales and Market Share by Manufacturers
8.3 Spain Generic Drugs Sales and Market Share by Type
8.4 Spain Generic Drugs Sales and Market Share by Application

9 BENELUX GENERIC DRUGS (VOLUME, VALUE AND SALES PRICE)

9.1 Benelux Generic Drugs Sales and Value (2011-2016)
  9.1.1 Benelux Generic Drugs Sales and Growth Rate (2011-2016)
  9.1.2 Benelux Generic Drugs Revenue and Growth Rate (2011-2016)
  9.1.9 Benelux Generic Drugs Sales Price Trend (2011-2016)
9.2 Benelux Generic Drugs Sales and Market Share by Manufacturers
9.3 Benelux Generic Drugs Sales and Market Share by Type
9.4 Benelux Generic Drugs Sales and Market Share by Application

10 EUROPE GENERIC DRUGS MANUFACTURERS ANALYSIS

10.1 Teva Pharma.
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Generic Drugs Product Type, Application and Specification
    10.1.2.1 Pure (Non-branded) Generics
    10.1.2.2 Branded Generics
  10.1.3 Teva Pharma. Generic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.1.4 Main Business/Business Overview
10.2 Novartis company
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Generic Drugs Product Type, Application and Specification
    10.2.2.1 Pure (Non-branded) Generics
    10.2.2.2 Branded Generics
  10.2.3 Novartis company Generic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.2.4 Main Business/Business Overview
10.3 Mylan
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Generic Drugs Product Type, Application and Specification
    10.3.2.1 Pure (Non-branded) Generics
    10.3.2.2 Branded Generics
  10.3.3 Mylan Generic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.3.4 Main Business/Business Overview
10.4 Allergan
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Generic Drugs Product Type, Application and Specification
    10.4.2.1 Pure (Non-branded) Generics
    10.4.2.2 Branded Generics
  10.4.3 Allergan Generic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.4.4 Main Business/Business Overview
10.5 Hospira
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Generic Drugs Product Type, Application and Specification
    10.5.2.1 Pure (Non-branded) Generics
    10.5.2.2 Branded Generics
  10.5.3 Hospira Generic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.5.4 Main Business/Business Overview
10.6 Dr. Reddy’s Lab.
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Generic Drugs Product Type, Application and Specification
    10.6.2.1 Pure (Non-branded) Generics
    10.6.2.2 Branded Generics
  10.6.3 Dr. Reddy’s Lab. Generic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.6.4 Main Business/Business Overview
10.7 Stada
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Generic Drugs Product Type, Application and Specification
    10.7.2.1 Pure (Non-branded) Generics
    10.7.2.2 Branded Generics
  10.7.3 Stada Generic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.7.4 Main Business/Business Overview
10.8 Greenstone
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Generic Drugs Product Type, Application and Specification
    10.8.2.1 Pure (Non-branded) Generics
    10.8.2.2 Branded Generics
  10.8.3 Greenstone Generic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.8.4 Main Business/Business Overview
10.9 Par Pharma
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Generic Drugs Product Type, Application and Specification
    10.9.2.1 Pure (Non-branded) Generics
    10.9.2.2 Branded Generics
  10.9.3 Par Pharma Generic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.9.4 Main Business/Business Overview
10.10 Sun Pharmaceutical
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Generic Drugs Product Type, Application and Specification
    10.10.2.1 Pure (Non-branded) Generics
    10.10.2.2 Branded Generics
  10.10.3 Sun Pharmaceutical Generic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.10.4 Main Business/Business Overview
10.11 Aspen Pharmacare
10.12 Fresenius
10.13 Lupin

11 GENERIC DRUGS MANUFACTURING COST ANALYSIS

11.1 Generic Drugs Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Generic Drugs

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Generic Drugs Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Generic Drugs Major Manufacturers in 2015
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 EUROPE GENERIC DRUGS MARKET FORECAST (2016-2021)

14.1 Germany Generic Drugs Sales Forecast (2016-2021)
14.2 France Generic Drugs Sales Forecast (2016-2021)
14.3 UK Generic Drugs Sales Forecast (2016-2021)
14.4 Russia Generic Drugs Sales Forecast (2016-2021)
14.5 Italy Generic Drugs Sales Forecast (2016-2021)
14.6 Spain Generic Drugs Sales Forecast (2016-2021)
14.7 Benelux Generic Drugs Sales Forecast (2016-2021)
14.8 Europe Generic Drugs Sales Forecast by Type (2016-2021)
14.9 Europe Generic Drugs Sales Forecast by Application (2016-2021)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Generic Drugs
Table Classification of Generic Drugs
Figure Europe Sales Market Share of Generic Drugs by Type in 2015
Figure Pure (Non-branded) Generics Picture
Figure Branded Generics Picture
Figure Super Generics Picture
Table Application of Generic Drugs
Figure Europe Sales Market Share of Generic Drugs by Application in 2015
Figure Cardiovascular & Hypertension Examples
Figure Dermatology Examples
Figure Diabetes Examples
Figure Rheumatology Examples
Figure Oncology Examples
Figure Gastrointestinal Examples
Figure Others Examples
Figure Germany Generic Drugs Revenue and Growth Rate (2011-2021)
Figure France Generic Drugs Revenue and Growth Rate (2011-2021)
Figure UK Generic Drugs Revenue and Growth Rate (2011-2021)
Figure Russia Generic Drugs Revenue and Growth Rate (2011-2021)
Figure Italy Generic Drugs Revenue and Growth Rate (2011-2021)
Figure Spain Generic Drugs Revenue and Growth Rate (2011-2021)
Figure Benelux Generic Drugs Revenue and Growth Rate (2011-2021)
Figure Europe Generic Drugs Sales and Growth Rate (2011-2021)
Figure Europe Generic Drugs Revenue and Growth Rate (2011-2021)
Table Europe Generic Drugs Sales of Key Manufacturers (2015 and 2016)
Table Europe Generic Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Generic Drugs Sales Share by Manufacturers
Figure 2016 Generic Drugs Sales Share by Manufacturers
Table Europe Generic Drugs Revenue by Manufacturers (2015 and 2016)
Table Europe Generic Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Generic Drugs Revenue Share by Manufacturers
Table 2016 Europe Generic Drugs Revenue Share by Manufacturers
Table Europe Generic Drugs Sales and Market Share by Type (2011-2016)
Table Europe Generic Drugs Sales Share by Type (2011-2016)
Figure Sales Market Share of Generic Drugs by Type (2011-2016)
Figure Europe Generic Drugs Sales Growth Rate by Type (2011-2016)
Table Europe Generic Drugs Revenue and Market Share by Type (2011-2016)
Table Europe Generic Drugs Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Generic Drugs by Type (2011-2016)
Figure Europe Generic Drugs Revenue Growth Rate by Type (2011-2016)
Table Europe Generic Drugs Sales and Market Share by Countries (2011-2016)
Table Europe Generic Drugs Sales Share by Countries (2011-2016)
Figure Sales Market Share of Generic Drugs by Countries (2011-2016)
Table Europe Generic Drugs Revenue and Market Share by Countries (2011-2016)
Table Europe Generic Drugs Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Generic Drugs by Countries (2011-2016)
Table Europe Generic Drugs Sales and Market Share by Application (2011-2016)
Table Europe Generic Drugs Sales Share by Application (2011-2016)
Figure Sales Market Share of Generic Drugs by Application (2011-2016)
Figure Germany Generic Drugs Sales and Growth Rate (2011-2016)
Figure Germany Generic Drugs Revenue and Growth Rate (2011-2016)
Figure Germany Generic Drugs Sales Price Trend (2011-2016)
Table Germany Generic Drugs Sales by Manufacturers (2015 and 2016)
Table Germany Generic Drugs Market Share by Manufacturers (2015 and 2016)
Table Germany Generic Drugs Sales by Type (2015 and 2016)
Table Germany Generic Drugs Market Share by Type (2015 and 2016)
Table Germany Generic Drugs Sales by Application (2015 and 2016)
Table Germany Generic Drugs Market Share by Application (2015 and 2016)
Figure France Generic Drugs Sales and Growth Rate (2011-2016)
Figure France Generic Drugs Revenue and Growth Rate (2011-2016)
Figure France Generic Drugs Sales Price Trend (2011-2016)
Table France Generic Drugs Sales by Manufacturers (2015 and 2016)
Table France Generic Drugs Market Share by Manufacturers (2015 and 2016)
Table France Generic Drugs Sales by Type (2015 and 2016)
Table France Generic Drugs Market Share by Type (2015 and 2016)
Table France Generic Drugs Sales by Application (2015 and 2016)
Table France Generic Drugs Market Share by Application (2015 and 2016)
Figure UK Generic Drugs Sales and Growth Rate (2011-2016)
Figure UK Generic Drugs Revenue and Growth Rate (2011-2016)
Figure UK Generic Drugs Sales Price Trend (2011-2016)
Table UK Generic Drugs Sales by Manufacturers (2015 and 2016)
Table UK Generic Drugs Market Share by Manufacturers (2015 and 2016)
Table UK Generic Drugs Sales by Type (2015 and 2016)
Table UK Generic Drugs Market Share by Type (2015 and 2016)
Table UK Generic Drugs Sales by Application (2015 and 2016)
Table UK Generic Drugs Market Share by Application (2015 and 2016)
Figure Russia Generic Drugs Sales and Growth Rate (2011-2016)
Figure Russia Generic Drugs Revenue and Growth Rate (2011-2016)
Figure Russia Generic Drugs Sales Price Trend (2011-2016)
Table Russia Generic Drugs Sales by Manufacturers (2015 and 2016)
Table Russia Generic Drugs Market Share by Manufacturers (2015 and 2016)
Table Russia Generic Drugs Sales by Type (2015 and 2016)
Table Russia Generic Drugs Market Share by Type (2015 and 2016)
Table Russia Generic Drugs Sales by Application (2015 and 2016)
Table Russia Generic Drugs Market Share by Application (2015 and 2016)
Figure Italy Generic Drugs Sales and Growth Rate (2011-2016)
Figure Italy Generic Drugs Revenue and Growth Rate (2011-2016)
Figure Italy Generic Drugs Sales Price Trend (2011-2016)
Table Italy Generic Drugs Sales by Manufacturers (2015 and 2016)
Table Italy Generic Drugs Market Share by Manufacturers (2015 and 2016)
Table Italy Generic Drugs Sales by Type (2015 and 2016)
Table Italy Generic Drugs Market Share by Type (2015 and 2016)
Table Italy Generic Drugs Sales by Application (2015 and 2016)
Table Italy Generic Drugs Market Share by Application (2015 and 2016)
Figure Spain Generic Drugs Sales and Growth Rate (2011-2016)
Figure Spain Generic Drugs Revenue and Growth Rate (2011-2016)
Figure Spain Generic Drugs Sales Price Trend (2011-2016)
Table Spain Generic Drugs Sales by Manufacturers (2015 and 2016)
Table Spain Generic Drugs Market Share by Manufacturers (2015 and 2016)
Table Spain Generic Drugs Sales by Type (2015 and 2016)
Table Spain Generic Drugs Market Share by Type (2015 and 2016)
Table Spain Generic Drugs Sales by Application (2015 and 2016)
Table Spain Generic Drugs Market Share by Application (2015 and 2016)
Figure Benelux Generic Drugs Sales and Growth Rate (2011-2016)
Figure Benelux Generic Drugs Revenue and Growth Rate (2011-2016)
Figure Benelux Generic Drugs Sales Price Trend (2011-2016)
Table Benelux Generic Drugs Sales by Manufacturers (2015 and 2016)
Table Benelux Generic Drugs Market Share by Manufacturers (2015 and 2016)
Table Benelux Generic Drugs Sales by Type (2015 and 2016)
Table Benelux Generic Drugs Market Share by Type (2015 and 2016)
Table Benelux Generic Drugs Sales by Application (2015 and 2016)
Table Benelux Generic Drugs Market Share by Application (2015 and 2016)
Table Generic Drugs Basic Information List
Table Teva Pharma. Generic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Teva Pharma. Generic Drugs Sales Market Share (2011-2016)
Table Novartis company Basic Information List
Table Novartis company Generic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis company Generic Drugs Sales Market Share (2011-2016)
Table Mylan Basic Information List
Table Mylan Generic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Mylan Generic Drugs Sales Market Share (2011-2016)
Table Allergan Basic Information List
Table Allergan Generic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Allergan Generic Drugs Sales Market Share (2011-2016)
Table Hospira Basic Information List
Table Hospira Generic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Hospira Generic Drugs Sales Market Share (2011-2016)
Table Dr. Reddy’s Lab. Basic Information List
Table Dr. Reddy’s Lab. Generic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Dr. Reddy’s Lab. Generic Drugs Sales Market Share (2011-2016)
Table Stada Basic Information List
Table Stada Generic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Stada Generic Drugs Sales Market Share (2011-2016)
Table Greenstone Basic Information List
Table Greenstone Generic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Greenstone Generic Drugs Sales Market Share (2011-2016)
Table Par Pharma Basic Information List
Table Par Pharma Generic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Par Pharma Generic Drugs Sales Market Share (2011-2016)
Table Sun Pharmaceutical Basic Information List
Table Sun Pharmaceutical Generic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sun Pharmaceutical Generic Drugs Sales Market Share (2011-2016)
Table Aspen Pharmacare Basic Information List
Table Fresenius Basic Information List
Table Lupin Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Generic Drugs
Figure Manufacturing Process Analysis of Generic Drugs
Figure Generic Drugs Industrial Chain Analysis
Table Raw Materials Sources of Generic Drugs Major Manufacturers in 2015
Table Major Buyers of Generic Drugs
Table Distributors/Traders List
Figure Germany Generic Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Germany Generic Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure France Generic Drugs Sales and Growth Rate Forecast (2016-2021)
Figure France Generic Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure UK Generic Drugs Sales and Growth Rate Forecast (2016-2021)
Figure UK Generic Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Generic Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Russia Generic Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Generic Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Italy Generic Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Generic Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Spain Generic Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Generic Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Generic Drugs Revenue and Growth Rate Forecast (2016-2021)
Table Europe Generic Drugs Sales Forecast by Type (2016-2021)
Table Europe Generic Drugs Sales Forecast by Application (2016-2021)